| abstract |
[PROBLEMS] To improve glucose tolerance and to reduce blood triglyceride observed in type II diabetes, impaired glucose tolerance, type II diabetes, hyperlipidemia, metabolic syndrome, visceral fat obesity, fatty liver or non To provide a drug effective as a prophylactic / therapeutic agent for alcoholic steatohepatitis. Compounds having xanthine oxidase inhibitory action, such as 1- (3-cyano-4-neopentyloxyphenyl) pyrazole-4-carboxylic acid, have an action to improve glucose tolerance reduction and blood levels observed in type II diabetes It has a triglyceride lowering action and can be used as a preventive or therapeutic agent for impaired glucose tolerance, type II diabetes, hyperlipidemia, metabolic syndrome, visceral fat obesity, fatty liver or nonalcoholic steatohepatitis. [Selection figure] None |